Pharmacological molecular pathways during an epileptic episode and dementia were examined in the current review, which offers a helpful therapeutic approach for the treatment of neurological illnesses. The current research states that various exceptional phyto-formulations are being created and have been validated by multiple clinical investigations. Because growth factors are expressed less frequently in the brains of people with Parkinson's or Alzheimer's disease, there is a correlation between poor endogenous protection and decreased neurogenesis and neuroplasticity. However, we speculate that the brain has a "neurodegenerative reserve" that may be used by growth factors or stem cell-neurorestoration therapies, at least in the early and middle stages of disease. However, further research is desperately needed to ascertain the optimal dosage and ratios for lowering the incidence of seizures.